Showing results (151-160 of 366) with videos related to

Sort By:
Pageof 37
Annals of the New York Academy of Sciences|January 1, 1989
In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W N Hittelman, H E Broxmeyer, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemoimmunotherapy for extensive non-oat cell lung cancerB F Issell, M Valdivieso, E M Hersh, et al.
Blood|October 1, 1987
Therapy of chronic myelogenous leukemia with recombinant interferon-gammaR Kurzrock, M Talpaz, H Kantarjian, et al.
Cancer Treatment Reports|February 1, 1976
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanomaJ U Gutterman, G M Mavligit, R Reed, et al.
Cancer|August 1, 1980
Evaluation of vindesine and MER in colorectal cancerA Y Bedikian, M Valdivieso, J Maroun, et al.
Cancer|January 15, 1992
Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastasesG M Mavligit, A A Zukiwski, C Charnsangavej, et al.
Cancer Research|October 1, 1986
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferonE S Kleinerman, R Kurzrock, D Wyatt, et al.
Annals of Internal Medicine|July 1, 1978
Nephrotoxicity from cancer immunotherapyG M Dosik, J U Gutterman, E M Hersh, et al.
Experimental Hematology|August 1, 1988
Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factorH E Broxmeyer, S Cooper, D E Williams, et al.
The New England Journal of Medicine|April 24, 1986
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K McCredie, et al.
Pageof 37